| Literature DB >> 28267235 |
Chao Wang1,2, Yanqi Ye1,2, Wujin Sun1,2, Jicheng Yu1,2, Jingqiang Wang1,2, David S Lawrence3,4,5, John B Buse6, Zhen Gu1,2,6.
Abstract
Glucose-responsive delivery of insulin mimicking the function of pancreatic β-cells to achieve meticulous control of blood glucose (BG) would revolutionize diabetes care. Here the authors report the development of a new glucose-responsive insulin delivery system based on the potential interaction between the glucose derivative-modified insulin (Glc-Insulin) and glucose transporters on erythrocytes (or red blood cells, RBCs) membrane. After being conjugated with the glucosamine, insulin can efficiently bind to RBC membranes. The binding is reversible in the setting of hyperglycemia, resulting in fast release of insulin and subsequent drop of BG level in vivo. The delivery vehicle can be further simplified utilizing injectable polymeric nanocarriers coated with RBC membrane and loaded with Glc-Insulin. The described work is the first demonstration of utilizing RBC membrane to achieve smart insulin delivery with fast responsiveness.Entities:
Keywords: diabetes; drug delivery; glucose response; insulin; red blood cell
Mesh:
Substances:
Year: 2017 PMID: 28267235 DOI: 10.1002/adma.201606617
Source DB: PubMed Journal: Adv Mater ISSN: 0935-9648 Impact factor: 30.849